We can’t show the full text here under this license. Use the link below to read it at the source.
Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair
Blocking integrin αVβ3 makes brain tumor cells more sensitive to temozolomide by reducing DNA repair
AI simplified
Abstract
Knockdown of integrin β3 increased sensitivity of high-grade glioma cells to temozolomide-induced cytotoxicity.
- Inhibition of integrin β3 led to the suppression of the FAK/Src/Akt/NFκB signaling pathway.
- Silencing integrin β3 resulted in the degradation of Rad51 and reduced repair of DNA double-strand breaks.
- Down-regulation of β3 did not further sensitize Rad51 knockdown cells to temozolomide, indicating a direct relationship.
- In β3-silenced cells exposed to temozolomide, cleavage of anti-apoptotic proteins and activation of caspases were observed.
- Increased γH2AX foci formation and altered NFκB signaling were confirmed in mouse glioma xenografts treated with the integrin inhibitor and temozolomide.
AI simplified